跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-5
首页
药物
M-5
M-5
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
CN 104744461 A
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2001
CN
US
19 件公开
US 6967208 B2
申请人: BRISTOL MYERS SQUIBB PHARMA CO
优先权: 2002
US
9 件公开
Ionic compounds with a delocalized anionic charge, and their use as ion conducting components or as catalysts
US 2005158631 A1
申请人: INST OF ORGANIC CHEMISTRY NAT
优先权: 2003
US
6 件公开
Phosphorus-containing compounds and uses thereof
US 7091213 B2
申请人: ARIAD GENE THERAPEUTICS INC
优先权: 2003
US
6 件公开
IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY
EP 4352038 A4
申请人: ARCTURUS THERAPEUTICS INC
优先权: 2021
CN
EP
US
WO
5 件公开
Liquid crystal mixture
US 6958176 B2
申请人: LI JI
优先权: 2000
EP
US
4 件公开
Angiogenesis inhibitors
US 7166293 B2
申请人: CARLSBAD TECHNOLOGY INC
优先权: 2002
CN
US
4 件公开
US 2007142449 A1
申请人: YUNG SHIN PHARMACEUTICAL IND
优先权: 2007
US
Spiropiperidine derivatives for controlling pests
US 7960401 B2
申请人: SYNGENTA CROP PROT INC
优先权: 2003
CN
US
4 件公开
Pentacyclic Anion Salt And Use Thereof As An Electrolyte
CN 104262259 A
申请人: CENTRE NAT RECH SCIENT
优先权: 2008
CN
US
4 件公开
Fused heterocyclic compound and use thereof
US 8158617 B2
申请人: SHIRAI JUNYA
优先权: 2006
US
4 件公开
Indazole derivatives for the treatment of cancer
EP 1723954 A1
申请人: CARLSBAD TECHNOLOGY INC
优先权: 2005
CN
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈